摘要
目的:观察穴位埋线对肥胖型多囊卵巢综合症患者的临床疗效。方法:选取2016年7月-2017年7月间本院门诊收治的肥胖型PCOS患者60例,随机将患者分为两组,各30例。实验组患者实施穴位埋线治疗,对照组患者实施二甲双胍药物治疗,治疗3个月后评价两组病例临床疗效。观察患者治疗前后腹围、体质指数(BMI)、月经情况、胰岛素抵抗指数(IR)等。结果:治疗前后比较,两组患者腹围、体质指数及胰岛素抵抗指数均降低,组间数据比较,实验组患者腹围及体质指数及胰岛素抵抗指数显著低于对照组,差异存在统计学意义(P<0.05);实验组月经改善总有效率为76.67%,对照组为53.33%,两组比较差异有统计学意义(P<0.05)。结论:穴位埋线在关于肥胖型PCOS患者临床治疗工作中可有效降低患者体重指数,促进排卵,改善脂肪代谢紊乱问题,降低其对自身胰岛素的抵抗效果,可治疗肥胖型多囊卵巢综合症,值得临床推广使用。
Objective： To observe the clinical efficacy of catgut implantation at acupoint on obese polycystic ovary syndrome. Methods： 60 cases were randomly divided into two groups, 30 cases in each. The experimental group was treated by catgut implantation at acupoint. The control group was given metformin. After 3 months, the clinical efficacy was evaluated. The abdominal circumference, BMI, menstrual condition and IR were observed. Results： Before and after treatment, BMI and IR in two groups were decreased. Those in the experimental group were significantly lower than the control group, and the difference shows statistically significant（P〈0.05）. The total efficiency of menstrual improvement was 76.67% in the experimental group and 53.33% in the control group, and there were statistically significant differences（P〈0.05）. Conclusion： Catgut implantation at acupoint can effectively reduce BMI, promote ovulation, improve the disorder of fat metabolism, reduce resistance to insulin, and is worthy of clinical popularization.
出处
《中医临床研究》
2018年第10期36-37,共2页
Clinical Journal Of Chinese Medicine
关键词
穴位埋线
二甲双胍
肥胖型多囊卵巢综合症
Catgut implantation at acupoint
Metformin
Obese polycystic ovary syndrome
